CytoTools AG (T5O.DE) XETRA

0.32

+0(+0.00%)

Updated at August 09, 2024 05:36PM

Currency In EUR

Valuation

Market Cap346,482
Enterprise Value-259,089
P/E Ratio-0.01
PEG Ratio-0
Price/Sales Ratio9.45
Price/Book Ratio0.39
Enterprise/Revenue-25.35
Enterprise/EBITDA0.56

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterDecember 31, 2023

Profitability

Profit Margin-1,203.7
Operating Margin-48.62

Management Effectiveness

Return On Assets-30.63
Return On Equity-1.91

Income Statement

Revenue17,404
Revenue/Share0.03
Gross Profit17,404
EBITDA-786,503.78
Net Income-20.95M
Diluted EPS-36.28

Balance Sheet

Total Cash612,832
Total Cash/Share1.06
Total Debt7,261
Total Debt/Equity0.02
Current Ratio4.37
Book Value Per Share0.81

Price History

52-Week Change-81.29
52-Week High3.53
52-Week Low0.32
Moving Average 50 Days1.54
Moving Average 200 Days1.78

Statistics

Average Volume973
Shares Outstanding513,749
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor103:100
Last Split DateApril 27, 2022